Top Stock Alerts for Day Traders: Applied Materials, ATP Oil & Gas, Boston …
Top Stock Alerts for Day Traders: Applied Materials, ATP Oil & Gas, Boston …
Filed under: Boston Drug Use
Boston Scientific Corporation (NYSE:BSX) has recently received US Food and Drug Administration approval for use of its Ion and Taxus Liberete stents in heart attack patients. Investors may want to find out how company insiders like Executive Officers …
Read more on MarketWatch (press release)
Former Celtic warns students about drug use
Filed under: Boston Drug Use
By Jaime Rebhan | Feb 21, 2012 Former Boston Celtic Chris Herren spoke to Wareham High School students about drug addiction on February 17. The Fall River native was a high school basketball star with a scholarship to Boston College and a promising …
Read more on Wareham Week
Pills as good as stents for some patients: study
Filed under: Boston Drug Use
CHICAGO (Reuters) – Treating stable heart patients with a handful of pills works just as well as propping open blocked heart arteries with a stent, US researchers said on Monday, adding to evidence that less-invasive, less-costly drug treatment works …
Read more on Chicago Tribune
From Twitter:
Boston Scientific Receives Industry’s First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients – by DiscovFOV (Angelo Brady)
From Twitter:
FDA approves Boston DES stents for use in AMI patients – The US Food and Drug Administration FDA has approved Boston… http://t.co/k0T99PdY – by TheNakedCell (TNC Bio)
From Twitter:
FDA approves Boston DES stents for use in AMI patients: The US Food and Drug Administration FDA has approved Bos… http://t.co/78bH67rC – by DiscoveryDrug (Drug Discovery)
Tags: drug addict, myocardial infarction, applied materials, boston celtic, heart attack patients